These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1225244)

  • 1. [Butaclamol in acute schizophrenia].
    Gallart Capdevila JM
    Arch Neurobiol (Madr); 1975; 38(6):545-86. PubMed ID: 1225244
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings: Butaclamol in the treatment of schizophrenia--a comparison of two treatment methods.
    Imaz F; Ban TA; Lehmann HE
    Psychopharmacol Bull; 1976 Jan; 12(1):31-4. PubMed ID: 1826
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of butaclamol in chronic schizophrenic patients.
    Clark ML; Paredes A; Costiloe JP; Wood F
    J Clin Pharmacol; 1977; 17(8-9):529-36. PubMed ID: 19510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Butaclamol hydrochloride in newly admitted schizophrenics.
    Hollister LE; Davis KL; Berger PA
    Psychopharmacol Commun; 1975; 1(5):493-500. PubMed ID: 778939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prolonged treatment with noxiptilin in depressions].
    Kröger R
    Arzneimittelforschung; 1969 Jun; 19():Suppl 5a:903+. PubMed ID: 5819772
    [No Abstract]   [Full Text] [Related]  

  • 6. [Butriptyline in 60 depressed patients].
    Pérez de Francisco C; Castilla J; Nieto Gómez D
    Prensa Med Mex; 1973; 38(7):290-2. PubMed ID: 4789186
    [No Abstract]   [Full Text] [Related]  

  • 7. Butaclamol in the treatment of schizophrenia. A standard-controlled clinical trial.
    Nestoros JN; Lehmann HE; Ban TA
    Int Pharmacopsychiatry; 1978; 13(3):138-50. PubMed ID: 355181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protrptyline in the treatment of chronic schizophrenic patients.
    Arbitman R; Yurtcu A; Lehmann HE; Sterlin C; Ban TA; Jarrold L
    Curr Ther Res Clin Exp; 1970 Mar; 12(3):131-5. PubMed ID: 4985491
    [No Abstract]   [Full Text] [Related]  

  • 9. [First results of symptom statistical studies on the characterization of the clinical effect profile of the antidepressive agent noxiptilin].
    Bente D; Engelmeier MP; Heinrich K; Hippius H; Schmitt W
    Arzneimittelforschung; 1969 Jun; 19():Suppl 5a:889+. PubMed ID: 5819770
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical studies with noxiptilin in long-term hospitalized schizophrenic patients].
    Döhner W; Eckmann F
    Arzneimittelforschung; 1969 Jun; 19():Suppl 5a:908+. PubMed ID: 4895497
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical and quantitative electroencephalographical effects of MK 940.
    Gannon P; Itil T; Keskiner A; Hsu B
    Arzneimittelforschung; 1970 Jul; 20(7):971-4. PubMed ID: 4918922
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical-psychiatric observations with noxiptilin in depressive syndromes].
    Hildebrandt HJ
    Arzneimittelforschung; 1969 Jun; 19():Suppl 5a:905+. PubMed ID: 5819773
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical experience with butriptyline hydrochloride. Study of 20 patients with depressive anxiety syndrome (author's transl)].
    Rangel Guerra R; Garcia L
    Prensa Med Mex; 1975; 40(11-12):360-6. PubMed ID: 1243779
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical test of noxiptilin in the scope of cooperative testing in 5 psychiatric hospitals].
    Eckmann F; Immich H; Neumann H; Schäpperle O; Schwarz H; Tempel H
    Arzneimittelforschung; 1969 Jun; 19():Suppl 5a:893+. PubMed ID: 4895493
    [No Abstract]   [Full Text] [Related]  

  • 15. [Noxiptilin in the treatment of psychogenic depressive syndromes].
    Strzyźewski W; Rajewski A; Sydor L; Kapelski Z
    Psychiatr Pol; 1978; 12(4):532-3. PubMed ID: 581521
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical experience with butriptyline (AY-62014) in the treatment of depressions.
    González M; Montaño H
    J Med; 1971; 2(5):296-9. PubMed ID: 4948364
    [No Abstract]   [Full Text] [Related]  

  • 17. [Importance of 1694 in phoniatrics].
    Cornut G
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1977 Nov; 26(9):729-34. PubMed ID: 146070
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical cooperative testing of the antidepressive agent noxiptilin in the University Neuroclinics of Kiel, Mainz and Marburg].
    Boeters U; Grahmann H; Petrilowitsch N; Reckel K; Spiegelberg U
    Arzneimittelforschung; 1969 Jun; 19():Suppl 5a:895+. PubMed ID: 4895494
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical evaluation and statistic analysis of noxiptilin testing results in the University Neuroclinic at Marburg-L].
    Spiegelberg U; Ihm P; Betz B
    Arzneimittelforschung; 1969 Jun; 19():Suppl 5a:897+. PubMed ID: 4895495
    [No Abstract]   [Full Text] [Related]  

  • 20. Pilot study with cyclobenzaprine in idiopathic Parkinsonism.
    Korten JJ; van Hemert J
    Psychiatr Neurol Neurochir; 1973; 76(2):119-28. PubMed ID: 4700930
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.